insulin therapy

PODCAST: Treatment Options for a Young, Newly Diagnosed Patient with a High BMI

Tags: DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)

Treatment Options for a Young, Newly Diagnosed Patient with a High BMI

Posted May 29, 2013 by John L. Leahy, MD

Tags: DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD

Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society.

Seaquist, Elizabeth R; Anderson, John; Childs, Belinda; Cryer, Philip; Dagogo-Jack, Samuel; Fish, Lisa; Heller, Simon R; Rodriguez, Henry; Rosenzweig, James; Vigersky, Robert

Diabetes care; 2013 May;36(5):1384-95. PMID: 23589542;

Category: General Reviews;

Tags: beta cell pathophysiology, glycemic control, insulin therapy, sulfonylureas (SUs), weight

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi, Silvio E; Bergenstal, Richard M; Buse, John B; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L; Tsapas, Apostolos; Wender, Richard; Matthews, David R

Diabetes care; 2012 Jun;35(6):1364-79. PMID: 22517736;

Category: Additional Resources / Guidelines;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes

Case 6: A Newly Diagnosed Patient with a High BMI

Tags: DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin

A 38-year-old Caucasian male presents to your office reporting symptoms of fatigue, thirst, and weight loss. He has not been to a physician since his late 20s.